High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia.
Feldman
E J
EJ
Department of Medicine, The Joan and Sanford Weill Medical College of Cornell University, New York Presbyterian Hospital, NY 10021, USA.
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine